Profile | GDS4284 / 1553839_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 92.9374 | 35 |
GSM687648 | Patient 402 control | 92.3324 | 34 |
GSM687653 | Patient 403 control | 216.912 | 51 |
GSM687658 | Patient 404 control | 223.988 | 50 |
GSM687663 | Patient 411 control | 234.082 | 50 |
GSM687668 | Patient 422 control | 186.353 | 47 |
GSM687673 | Patient 424 control | 217.395 | 49 |
GSM687678 | Patient 425 control | 306.444 | 55 |
GSM687683 | Patient 427 control | 214.504 | 48 |
GSM687688 | Patient 428 control | 249.371 | 53 |
GSM687695 | Patient 441 control | 313.23 | 50 |
GSM687699 | Patient 443 control | 471.568 | 61 |
GSM687704 | Patient 444 control | 124.736 | 39 |
GSM687707 | Patient 448 control | 143.481 | 37 |
GSM687712 | Patient 449 control | 185.785 | 46 |
GSM687719 | Patient 450 control | 514.104 | 63 |
GSM687724 | Patient 451 control | 95.8583 | 31 |
GSM687728 | Patient 452 control | 369.069 | 59 |
GSM687646 | Patient 401 treated 24h | 125.595 | 39 |
GSM687649 | Patient 402 treated 24h | 343.306 | 58 |
GSM687665 | Patient 411 treated 24h | 364.089 | 58 |
GSM687651 | Patient 402 treated 4 weeks | 252.518 | 52 |
GSM687667 | Patient 411 treated 4 weeks | 257.862 | 52 |
GSM687670 | Patient 422 treated 24h | 245.598 | 51 |
GSM687671 | Patient 422 treated 4 weeks | 308.986 | 56 |
GSM687654 | Patient 403 treated 24h | 233.432 | 53 |
GSM687675 | Patient 424 treated 24h | 211.999 | 47 |
GSM687685 | Patient 427 treated 24h | 94.0013 | 33 |
GSM687656 | Patient 403 treated 4 weeks | 226.45 | 52 |
GSM687677 | Patient 424 treated 4 weeks | 98.8575 | 34 |
GSM687687 | Patient 427 treated 4 weeks | 143.344 | 44 |
GSM687692 | Patient 428 treated 4h | 116.706 | 37 |
GSM687716 | Patient 449 treated 4h | 73.5664 | 29 |
GSM687722 | Patient 450 treated 4h | 64.2156 | 24 |
GSM687680 | Patient 425 treated 24h | 252.193 | 52 |
GSM687690 | Patient 428 treated 24h | 189.299 | 48 |
GSM687700 | Patient 443 treated 24h | 89.5717 | 25 |
GSM687705 | Patient 444 treated 24h | 69.4983 | 29 |
GSM687714 | Patient 449 treated 24h | 27.5306 | 17 |
GSM687721 | Patient 450 treated 24h | 169.406 | 41 |
GSM687682 | Patient 425 treated 4 weeks | 131.582 | 41 |
GSM687694 | Patient 428 treated 4 weeks | 200.878 | 50 |
GSM687702 | Patient 443 treated 4 weeks | 46.1161 | 21 |
GSM687718 | Patient 449 treated 4 weeks | 129.437 | 39 |
GSM687723 | Patient 450 treated 4 weeks | 125.362 | 37 |
GSM687661 | Patient 404 treated 4h | 51.5189 | 22 |
GSM687710 | Patient 448 treated 4h | 340.222 | 58 |
GSM687726 | Patient 451 treated 4h | 182.861 | 43 |
GSM687730 | Patient 452 treated 4h | 721.544 | 66 |
GSM687660 | Patient 404 treated 24h | 92.3474 | 28 |
GSM687697 | Patient 441 treated 24h | 118.264 | 31 |
GSM687709 | Patient 448 treated 24h | 343.928 | 57 |
GSM687725 | Patient 451 treated 24h | 130.512 | 35 |
GSM687729 | Patient 452 treated 24h | 107.655 | 29 |
GSM687727 | Patient 451 treated 4 weeks | 267.568 | 51 |
GSM687731 | Patient 452 treated 4 weeks | 158.979 | 41 |